What happens with colorectal cancer risk in women taking estrogen alone (without progestin) or other E+P formulas?
The current report addresses only the issue of E+P use in the form of pills. Final results from the ongoing estrogen alone (E alone) study are unknown at this time. Participants in the E alone study are asked to continue to take the study pills and to come for the regular clinic visits. The National Heart, Lung and Blood Institute which overseas WHI, continues to review the study for women receiving E-alone and they will provide investigators and participants with any new information about the study that might affect their participation. This information has been superceded by the 2004 Hormone Program Update.
Related Questions
- Is there an increased risk of breast cancer and abnormal mammograms in women taking estrogen alone (without progestin) or other E+P formulas?
- What happens with colorectal cancer risk in women taking estrogen alone (without progestin) or other E+P formulas?
- What was the decreased risk for women taking estrogen plus progestin for colorectal cancer?
